Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
![]() |
Anti-obesity drug discovery: advances and challengesNature reviews. Drug discovery, 2022-03, Vol.21 (3), p.201-223 [Peer Reviewed Journal]2021. Springer Nature Limited. ;Springer Nature Limited 2021 ;ISSN: 1474-1776 ;EISSN: 1474-1784 ;DOI: 10.1038/s41573-021-00337-8 ;PMID: 34815532Full text available |
2 |
Material Type: Article
|
![]() |
Pharmacological Management of Obesity: An Endocrine Society Clinical Practice GuidelineThe journal of clinical endocrinology and metabolism, 2015-02, Vol.100 (2), p.342-362 [Peer Reviewed Journal]Copyright © 2015 by the Endocrine Society ;Copyright © 2015 by The Endocrine Society ;ISSN: 0021-972X ;EISSN: 1945-7197 ;DOI: 10.1210/jc.2014-3415 ;PMID: 25590212Full text available |
3 |
Material Type: Article
|
![]() |
A Dozen Years of Discovery: Insights into the Physiology and Pharmacology of FGF21Cell metabolism, 2019-02, Vol.29 (2), p.246-253 [Peer Reviewed Journal]2019 Elsevier Inc. ;Copyright © 2019 Elsevier Inc. All rights reserved. ;ISSN: 1550-4131 ;EISSN: 1932-7420 ;DOI: 10.1016/j.cmet.2019.01.004 ;PMID: 30726758Full text available |
4 |
Material Type: Article
|
![]() |
Cardiovascular and Metabolic Heterogeneity of Obesity: Clinical Challenges and Implications for ManagementCirculation (New York, N.Y.), 2018-03, Vol.137 (13), p.1391-1406 [Peer Reviewed Journal]2018 by the American College of Cardiology Foundation and the American Heart Association, Inc. ;2018 American Heart Association, Inc. ;ISSN: 0009-7322 ;EISSN: 1524-4539 ;DOI: 10.1161/CIRCULATIONAHA.117.029617 ;PMID: 29581366Full text available |
5 |
Material Type: Article
|
![]() |
Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)Diabetes care, 2018-12, Vol.41 (12), p.2669-2701 [Peer Reviewed Journal]2018 American Diabetes Association and European Association for the Study of Diabetes. ;Copyright American Diabetes Association Dec 1, 2018 ;2018 American Diabetes Association and European Association for the Study of Diabetes. 2018 ;ISSN: 0149-5992 ;EISSN: 1935-5548 ;DOI: 10.2337/dci18-0033 ;PMID: 30291106Full text available |
6 |
Material Type: Article
|
![]() |
Tirzepatide Once Weekly for the Treatment of ObesityThe New England journal of medicine, 2022-07, Vol.387 (3), p.205-216 [Peer Reviewed Journal]Copyright © 2022 Massachusetts Medical Society. All rights reserved. ;Copyright © 2022 Massachusetts Medical Society. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2206038 ;PMID: 35658024Full text available |
7 |
Material Type: Article
|
![]() |
Once-Weekly Semaglutide in Adults with Overweight or ObesityThe New England journal of medicine, 2021-03, Vol.384 (11), p.989-1002 [Peer Reviewed Journal]Copyright © 2021 Massachusetts Medical Society. All rights reserved. ;Copyright © 2021 Massachusetts Medical Society. ;COPYRIGHT 2021 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2032183 ;PMID: 33567185Full text available |
8 |
Material Type: Article
|
![]() |
Comprehensive Review in Current Developments of Imidazole‐Based Medicinal ChemistryMedicinal research reviews, 2014-03, Vol.34 (2), p.340-437 [Peer Reviewed Journal]2013 Wiley Periodicals, Inc. ;ISSN: 0198-6325 ;EISSN: 1098-1128 ;DOI: 10.1002/med.21290 ;PMID: 23740514 ;CODEN: MRREDDFull text available |
9 |
Material Type: Article
|
![]() |
Targeting adipose tissue in the treatment of obesity-associated diabetesNature reviews. Drug discovery, 2016-09, Vol.15 (9), p.639-660 [Peer Reviewed Journal]Copyright Nature Publishing Group Sep 2016 ;ISSN: 1474-1776 ;EISSN: 1474-1784 ;DOI: 10.1038/nrd.2016.75 ;PMID: 27256476Full text available |
10 |
Material Type: Article
|
![]() |
Treatment of Obesity with CelastrolCell, 2015-05, Vol.161 (5), p.999-1011 [Peer Reviewed Journal]2015 Elsevier Inc. ;Copyright © 2015 Elsevier Inc. All rights reserved. ;ISSN: 0092-8674 ;EISSN: 1097-4172 ;DOI: 10.1016/j.cell.2015.05.011 ;PMID: 26000480Full text available |
11 |
Material Type: Article
|
![]() |
Unimolecular Polypharmacy for Treatment of Diabetes and ObesityCell metabolism, 2016-07, Vol.24 (1), p.51-62 [Peer Reviewed Journal]2016 Elsevier Inc. ;Copyright © 2016 Elsevier Inc. All rights reserved. ;ISSN: 1550-4131 ;EISSN: 1932-7420 ;DOI: 10.1016/j.cmet.2016.06.021 ;PMID: 27411008Full text available |
12 |
Material Type: Article
|
![]() |
A Randomized, Controlled Trial of Liraglutide for Adolescents with ObesityThe New England journal of medicine, 2020-05, Vol.382 (22), p.2117-2128 [Peer Reviewed Journal]Copyright © 2020 Massachusetts Medical Society. All rights reserved. ;Copyright © 2020 Massachusetts Medical Society. ;ISSN: 0028-4793 ;ISSN: 1533-4406 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1916038 ;PMID: 32233338Full text available |
13 |
Material Type: Article
|
![]() |
The Science of Obesity Management: An Endocrine Society Scientific StatementEndocrine reviews, 2018-04, Vol.39 (2), p.79-132 [Peer Reviewed Journal]Copyright © 2018 Endocrine Society 2018 ;Copyright © Oxford University Press 2015 ;COPYRIGHT 2018 Oxford University Press ;Copyright © 2018 Endocrine Society ;ISSN: 0163-769X ;EISSN: 1945-7189 ;DOI: 10.1210/er.2017-00253 ;PMID: 29518206Full text available |
14 |
Material Type: Article
|
![]() |
Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trialNature medicine, 2022-10, Vol.28 (10), p.2083-2091 [Peer Reviewed Journal]2022. The Author(s). ;The Author(s) 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2022 ;ISSN: 1078-8956 ;EISSN: 1546-170X ;DOI: 10.1038/s41591-022-02026-4 ;PMID: 36216945Full text available |
15 |
Material Type: Article
|
![]() |
Pharmacotherapy for adults with overweight and obesity: a systematic review and network meta-analysis of randomised controlled trialsThe Lancet (British edition), 2022-01, Vol.399 (10321), p.259-269 [Peer Reviewed Journal]Copyright © 2022 Elsevier Ltd. All rights reserved. ;2022. Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(21)01640-8 ;PMID: 34895470Full text available |
16 |
Material Type: Article
|
![]() |
Activation of Human Brown Adipose Tissue by a β3-Adrenergic Receptor AgonistCell metabolism, 2015-01, Vol.21 (1), p.33-38 [Peer Reviewed Journal]2015 Elsevier Inc. ;Copyright © 2015 Elsevier Inc. All rights reserved. ;2015 Elsevier Inc. 2015 ;ISSN: 1550-4131 ;EISSN: 1932-7420 ;DOI: 10.1016/j.cmet.2014.12.009 ;PMID: 25565203Full text available |
17 |
Material Type: Article
|
![]() |
Glucose-Dependent Insulinotropic Polypeptide Receptor-Expressing Cells in the Hypothalamus Regulate Food IntakeCell metabolism, 2019-11, Vol.30 (5), p.987-996.e6 [Peer Reviewed Journal]Copyright © 2019 The Authors. Published by Elsevier Inc. All rights reserved. ;2019 The Authors 2019 ;ISSN: 1550-4131 ;EISSN: 1932-7420 ;DOI: 10.1016/j.cmet.2019.07.013 ;PMID: 31447324Full text available |
18 |
Material Type: Article
|
![]() |
Physical activity enhances the improvement of body mass index and metabolism by inulin: a multicenter randomized placebo-controlled trial performed in obese individualsBMC medicine, 2022-03, Vol.20 (1), p.110-110, Article 110 [Peer Reviewed Journal]2022. The Author(s). ;COPYRIGHT 2022 BioMed Central Ltd. ;The Author(s) 2022 ;ISSN: 1741-7015 ;EISSN: 1741-7015 ;DOI: 10.1186/s12916-022-02299-z ;PMID: 35351144Full text available |
19 |
Material Type: Article
|
![]() |
Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trialThe Lancet (British edition), 2023-08, Vol.402 (10402), p.613-626 [Peer Reviewed Journal]2023 Elsevier Ltd ;Copyright © 2023 Elsevier Ltd. All rights reserved. ;2023. Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(23)01200-X ;PMID: 37385275Full text available |
20 |
Material Type: Article
|
![]() |
Chlorogenic acid (CGA): A pharmacological review and call for further researchBiomedicine & pharmacotherapy, 2018-01, Vol.97, p.67-74 [Peer Reviewed Journal]2017 Elsevier Masson SAS ;Copyright © 2017 Elsevier Masson SAS. All rights reserved. ;ISSN: 0753-3322 ;EISSN: 1950-6007 ;DOI: 10.1016/j.biopha.2017.10.064 ;PMID: 29080460Full text available |